ARCHIVES

Patenting the Gene: Cancer Advocates and Industry Diverge on Myriad Ruling

This article is from The Cancer Letter archive.

Vol. 39 No. 24 | June 14, 2013

Download PDF Visit The Full Archive

Related Articles

Cancer Policy: EMFs “Possible” Carcinogen, Panel Says; Plans Public Hearings

August 7, 1998

Deparle Leaves HCFA; Speyer Promoted At NYU Center.

September 15, 2000

In Brief: Walter Lawrence, Reginald Ho Lead ACS; Henderson To Leave Dana-Farber for UCSF

November 22, 1991

NCI Programs: Genetic Variations Discovered, Added to NCI Database

June 11, 1999

In Brief: FDA’s Tabor To Head Biological Carcinogenesis in DCE; Steve Larson to Leave NIH for Memorial

April 29, 1988

UPCI Puts the Cancer Letter on its Intranet for Employees

May 5, 2000